Carlyle Group Inc.
Institutional investor · Portfolio as of Q1 2022
Top Holdings7 positions
ATOTECH LTD | 153.7M | $3.4B | 40.3% | — | — | 5 qtrssince 2021-Q1 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC COMMON STOCK | 42.2M | $2.5B | 30.2% | $50.72 | +14.53% | 8 qtrssince 2020-Q2 | Decreased 0 |
ORTHO CLINICAL DIAGNOSTICS H | 118.1M | $2.2B | 26.4% | — | — | 5 qtrssince 2021-Q1 | Unchanged 0 |
1LIFE HEALTHCARE INC | 13.6M | $150.8M | 1.8% | — | — | 9 qtrssince 2020-Q1 | Unchanged 0 |
VITRU LTD | 6.2M | $98.7M | 1.2% | — | — | 7 qtrssince 2020-Q3 | Unchanged 0 |
SEACOR MARINE HLDGS INC COM | 1.1M | $9.3M | 0.1% | $11.28 | -24.66% | 14 qtrssince 2018-Q4 | Unchanged 0 |
SIRIUSPOINT LTD COM | 129,408 | $968,000 | 0.0% | $10.29 | -26.92% | 5 qtrssince 2021-Q1 | Unchanged 0 |
Carlyle Group Inc. manages $8.4B across 7 positions as of Q1 2022. Top holdings: ATC (40.3%), GTM (30.2%), OCDX (26.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.
Exited 1, trimmed 1. No standout high-conviction moves this quarter. Portfolio: $8.4B across 7 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR